Scholars@Duke

Improving the Oral Bioavailability and In vivo Efficacy of the TAK 1 Inhibitor, Takinib.

Research Grant
Duke Scholars
Timothy Arthur James Haystead
Principal Investigator Timothy Arthur James Haystead Pharmacology & Cancer Biology
Philip Hughes
Research Scientist Philip Hughes  

Administered By

Pharmacology & Cancer Biology

Awarded By

Eydis Bio Inc.

Start Date

September 18, 2019

End Date

August 31, 2021
 

Administered By

Pharmacology & Cancer Biology

Awarded By

Eydis Bio Inc.

Start Date

September 18, 2019

End Date

August 31, 2021